文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症相关30天风险标准化再入院:全国 Medicare 样本分析

Sepsis-Associated 30-Day Risk-Standardized Readmissions: Analysis of a Nationwide Medicare Sample.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论脓毒症幸存者30天风险标准化再入院率中位数28.7%,医院间差异大,且与院内质量指标呈正相关。

该横断面研究基于2008至2011年 Medicare 按服务收费数据库,纳入3315家医院共633407例脓毒症住院患者,计算医院层面的30天风险标准化再入院率。中位再入院率为28.7%(四分位距26.1-31.9),不同地区、教学状态、服务弱势患者比例及医院规模间存在差异。综合质量评分最高的医院再入院率反而最高(32.0% vs 27.5%),死亡率最高的医院再入院率较低(28.7% vs 30.7%)。作者认为可能存在风险标准化不足等多种解释,需进一步研究。

要点

  • 脓毒症幸存者30天风险标准化再入院率中位数为28.7%(IQR 26.1-31.9),即约三分之一幸存者再入院。
  • 教学医院再入院率高于非教学医院(31.1% vs 29.0%,p<0.001)。
  • 服务弱势患者比例最高的医院再入院率高于最低者(30.6% vs 28.7%,p<0.001)。
  • 综合质量评分最高的医院再入院率高于最低者(32.0% vs 27.5%,p<0.001)。
  • 死亡率最高的医院再入院率低于死亡率最低者(28.7% vs 30.7%,p<0.001)。

适用人群与场景

  • 2008至2011年 Medicare 按服务收费数据库中,采用 Angus 方法通过 ICD-9 编码识别的脓毒症住院患者。
  • 分析对象为脓毒症幸存者出院后的30天再入院,覆盖3315家参与 Medicare 的急性期医院。

研究设计与关键结果

  • 研究类型为横断面研究,样本为2008至2011年3315家医院的633407例脓毒症住院。
  • 中位风险标准化30天再入院率为28.7%(IQR 26.1-31.9)。
  • 地区差异:东北部30.4%、南部29.6%、中西部28.8%、西部27.7%(p<0.001)。
  • 教学医院再入院率31.1% vs 非教学医院29.0%(p<0.001)。
  • 服务弱势患者比例最高的医院30.6% vs 最低者28.7%(p<0.001)。
  • 综合质量评分最高的医院再入院率32.0% vs 最低者27.5%(p<0.001)。
  • 死亡率最高的医院再入院率28.7% vs 死亡率最低者30.7%(p<0.001)。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性;作者在结论中提出可能存在风险标准化不足等多种解释,需进一步研究。

对床旁实践的改变

  • 作者认为脓毒症幸存者再入院率高且医院间差异大,多种人口学和结构因素与差异相关。
  • 作者认为院内高质量指标与更高再入院率相关,可能存在风险标准化不足等多种解释,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine national readmission rates among sepsis survivors, variations in rates between hospitals, and determine whether measures of quality correlate with performance on sepsis readmissions.

DESIGN: Cross-sectional study of sepsis readmissions between 2008 and 2011 in the Medicare fee-for-service database.

SETTING: Acute care, Medicare participating hospitals from 2008 to 2011.

PATIENTS: Septic patients as identified by International Classification of Diseases, Ninth Revision codes using the Angus method.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We generated hospital-level, risk-standardized, 30-day readmission rates among survivors of sepsis and compared rates across region, ownership, teaching status, sepsis volume, hospital size, and proportion of underserved patients. We examined the relationship between risk-standardized readmission rates and hospital-level composite measures of quality and mortality. From 633,407 hospitalizations among 3,315 hospitals from 2008 to 2011, median risk-standardized readmission rates was 28.7% (interquartile range, 26.1-31.9). There were differences in risk-standardized readmission rates by region (Northeast, 30.4%; South, 29.6%; Midwest, 28.8%; and West, 27.7%; p < 0.001), teaching versus nonteaching status (31.1% vs 29.0%; p < 0.001), and hospitals serving the highest proportion of underserved patients (30.6% vs 28.7%; p < 0.001). The best performing hospitals on a composite quality measure had highest risk-standardized readmission rates compared with the lowest (32.0% vs 27.5%; p < 0.001). Risk-standardized readmission rates was lower in the highest mortality hospitals compared with those in the lowest (28.7% vs 30.7%; p < 0.001).

CONCLUSIONS: One third of sepsis survivors were readmitted and wide variation exists between hospitals. Several demographic and structural factors are associated with this variation. Measures of higher quality in-hospital care were correlated with higher readmission rates. Several potential explanations are possible including poor risk standardization, more research is needed.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Norman BC, Cooke CR, Ely EW, et al. Sepsis-Associated 30-Day Risk-Standardized Readmissions: Analysis of a Nationwide Medicare Sample. Crit Care Med. 2017. PMID: 28471814. doi:10.1097/CCM.0000000000002476

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。